Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxynitrite (ONOO-) is a potent, short-lived oxidant and nitrating agent formed by the diffusion-controlled reaction of nitric oxide and superoxide (Pacher et al., 2007, Physiol Rev). It is a central mediator of nitro-oxidative stress, capable of damaging proteins, lipids, and DNA through mechanisms such as tyrosine nitration and the initiation of radical chain reactions (Radi, 2013, Acc Chem Res). While it contributes to the immune system's antimicrobial defenses, its overproduction is implicated in the pathogenesis of various conditions, including neurodegenerative diseases, cardiovascular dysfunction, and chronic inflammation (Szabo et al., 2007, Nat Rev Drug Discov). Therapeutic strategies targeting peroxynitrite involve the use of scavengers or synthetic decomposition catalysts, such as metalloporphyrins, which facilitate its conversion to less reactive species. These interventions aim to restore redox homeostasis and prevent the activation of pro-apoptotic pathways and inflammatory cascades in diseased tissues. Furthermore, the development of these agents faces challenges due to the high reactivity and short half-life of the target species in vivo.
Direct scavenging of reactive species, catalytic decomposition into non-toxic products (e.g., nitrate), or inhibition of precursor radical formation from enzymes like iNOS and NADPH oxidase (Szabo et al., 2007, Nat Rev Drug Discov).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxynitrite and reactive nitrogen species (RNS).